Skip to main content

Data, Insight & Analysis

0
Recent Downloads

Biotech and Life Sciences

Houston is a hub for medical device manufacturing, pharmaceuticals, and research and development services.
Published on 6/20/18
Biotech and Life Sciences in Houston

The Houston region is home to more than 19,400 biotech specialists and 6,650 of the world’s top medical researchers. Nearly 4,200 clinical trials were active in the Houston region in ’17, representing 13.4 percent of all trials in the country.

In the field of health and medical technology, the Texas Medical Center’s Innovation Institute coordinates the efforts of several life science-focused incubator and accelerator programs. The organization aims to help startup companies commercialize new medical technologies by providing access to the vast resources of the world’s largest medical center.

The Innovation Institute’s accelerator program, TMCx, focuses on early-stage companies making breakthroughs in medical devices, digital health care services, diagnostics and therapeutics. A related program, TMCx+, is an incubator that targets seed-stage companies in the same sectors. To date, 84 companies are enrolled in the TMCx program and a total of $157 million funding is raised. The Texas Medical Center launched the TMC Venture Fund in ’17, which aims to invest $25 million in early stage health care tech companies in Houston.

TMC Innovation partners with two industry-backed programs supporting health innovation. Johnson & Johnson’s JLABs @TMC provides lab space and support to companies developing promising technologies in consumer health, medical devices and pharmaceuticals, while the AT&T Foundry supports companies developing digital health services.

Patrick Jankowski, CERP
Senior Vice President, Research
713-844-3616
pjankowski@houston.org

Josh Pherigo
Manager, Research
713-844-3617
jpherigo@houston.org

biotechnologyhealth carelife sciences
$25 million

Funding available from TMC for early stage health care tech companies

4,200

Number of local clinical trials in '17, 13.4 percent of the U.S.

Executive Partners